Goldman Sachs’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,651
| Closed | -$74K | – | 4606 |
|
|
2020
Q2 | $74K | Buy |
+1,651
| New | +$74K | ﹤0.01% | 4216 |
|
|
2017
Q3 | – | Sell |
-41
| Closed | -$35K | – | 4452 |
|
|
2017
Q2 | $35K | Buy |
41
+4
| +11% | +$3.42K | ﹤0.01% | 4285 |
|
|
2017
Q1 | $26K | Hold |
37
| – | – | ﹤0.01% | 4299 |
|
|
2016
Q4 | $27K | Sell |
37
-3
| -8% | -$2.19K | ﹤0.01% | 4322 |
|
|
2016
Q3 | $38K | Buy |
40
+3
| +8% | +$2.85K | ﹤0.01% | 4351 |
|
|
2016
Q2 | $53K | Hold |
37
| – | – | ﹤0.01% | 4264 |
|
|
2016
Q1 | $46K | Buy |
37
+5
| +16% | +$6.22K | ﹤0.01% | 4234 |
|
|
2015
Q4 | $42K | Hold |
32
| – | – | ﹤0.01% | 4229 |
|
|
2015
Q3 | $47K | Sell |
32
-6
| -16% | -$8.81K | ﹤0.01% | 4350 |
|
|
2015
Q2 | $85K | Buy |
38
+2
| +6% | +$4.47K | ﹤0.01% | 4337 |
|
|
2015
Q1 | $109K | Sell |
36
-27
| -43% | -$81.8K | ﹤0.01% | 4127 |
|
|
2014
Q4 | $208K | Sell |
63
-50
| -44% | -$165K | ﹤0.01% | 3950 |
|
|
2014
Q3 | $400K | Buy |
113
+52
| +85% | +$184K | ﹤0.01% | 3469 |
|
|
2014
Q2 | $234K | Buy |
61
+38
| +165% | +$146K | ﹤0.01% | 3874 |
|
|
2014
Q1 | $93K | Sell |
23
-10
| -30% | -$40.4K | ﹤0.01% | 4151 |
|
|
2013
Q4 | $123K | Buy |
33
+26
| +371% | +$96.9K | ﹤0.01% | 4038 |
|
|
2013
Q3 | $29K | Sell |
7
-14
| -67% | -$58K | ﹤0.01% | 4132 |
|
|
2013
Q2 | $212K | Buy |
+21
| New | +$212K | ﹤0.01% | 3608 |
|